<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epilepsia Open</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia Open</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2470-9239</journal-id>
<journal-id journal-id-type="publisher-id">EPI4</journal-id>
<journal-title-group>
<journal-title>Epilepsia Open</journal-title>
</journal-title-group>
<issn pub-type="epub">2470-9239</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30187003</article-id>
<article-id pub-id-type="pmc">6119748</article-id>
<article-id pub-id-type="doi">10.1002/epi4.12238</article-id>
<article-id pub-id-type="publisher-id">EPI412238</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Critical Review and Invited Commentary</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Critical Review and Invited Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Progress in the molecular mechanisms of genetic epilepsies using patient‐induced pluripotent stem cells</article-title>
<alt-title alt-title-type="left-running-head">R. Zhou et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="epi412238-cr-0001">
<name>
<surname>Zhou</surname>
<given-names>Ruijiao</given-names>
</name>
<xref ref-type="aff" rid="epi412238-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="epi412238-biog-0001">*</xref>
</contrib>
<contrib contrib-type="author" id="epi412238-cr-0002">
<name>
<surname>Jiang</surname>
<given-names>Guohui</given-names>
</name>
<xref ref-type="aff" rid="epi412238-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="epi412238-cr-0003">
<name>
<surname>Tian</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="epi412238-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="epi412238-cr-0004">
<name>
<surname>Wang</surname>
<given-names>Xuefeng</given-names>
</name>
<address>
<email>xfyp@163.com</email>
</address>
<xref ref-type="aff" rid="epi412238-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="epi412238-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<named-content content-type="organisation-division">the First Affiliated Hospital of Chongqing Medical University</named-content>
<institution>Chongqing Key Laboratory of Neurology</institution>
<named-content content-type="city">Chongqing</named-content>
<country country="CN">China</country>
</aff>
<aff id="epi412238-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<named-content content-type="organisation-division">Institute of Neurological Diseases</named-content>
<institution>Affiliated Hospital of North Sichuan Medical College</institution>
<named-content content-type="city">Nanchong</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Address correspondence to Xuefeng Wang, Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, 1 Youyi Road, Chongqing 400016, China. E‐mail: <email>xfyp@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>9</month>
<year>2018</year>
</pub-date>
<volume>3</volume>
<issue>3</issue>
<issue-id pub-id-type="doi">10.1002/epi4.2018.3.issue-3</issue-id>
<fpage>331</fpage>
<lpage>339</lpage>
<history>
<date date-type="accepted">
<day>25</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 International League Against Epilepsy <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Epilepsia Open</italic> published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy.</copyright-statement>
<license license-type="creativeCommonsBy-nc-nd">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EPI4-3-331.pdf" xlink:type="simple"></self-uri>
<abstract id="epi412238-abs-0001">
<title>Summary</title>
<p>Research findings on the molecular mechanisms of epilepsy almost always originate from animal experiments, and the development of induced pluripotent stem cell (<styled-content style="fixed-case">iPSC</styled-content>) technology allows the use of human cells with genetic defects for studying the molecular mechanisms of genetic epilepsy (<styled-content style="fixed-case">GE</styled-content>) for the first time. With <styled-content style="fixed-case">iPSC</styled-content> technology, terminally differentiated cells collected from <styled-content style="fixed-case">GE</styled-content> patients with specific genetic etiologies can be differentiated into many relevant cell subtypes that carry all of the <styled-content style="fixed-case">GE</styled-content> patient's genetic information. <styled-content style="fixed-case">iPSC</styled-content>s have opened up a new research field involving the pathogenesis of <styled-content style="fixed-case">GE</styled-content>. Using this approach, studies have found that gene mutations induce <styled-content style="fixed-case">GE</styled-content> by altering the balance between neuronal excitation and inhibition, which is associated. among other factors, with neuronal developmental disturbances, ion channel abnormalities, and synaptic dysfunction. Simultaneously, astrocyte activation, mitochondrial dysfunction, and abnormal signaling pathway activity are also important factors in the molecular mechanisms of GE.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="epi412238-kwd-0001">Genetic epilepsy</kwd>
<kwd id="epi412238-kwd-0002">Induced pluripotent stem cells</kwd>
<kwd id="epi412238-kwd-0003">Synapse</kwd>
<kwd id="epi412238-kwd-0004">Ion channels</kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="1"></table-count>
<page-count count="9"></page-count>
<word-count count="7367"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>epi412238</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>September 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.4 mode:remove_FC converted:03.09.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group id="epi412238-ntgp-0001">
<fn fn-type="equal" id="epi412238-note-1001">
<p>Ruijiao Zhou and Guohui Jiang contributed equally to this work.</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<p>
<boxed-text content-type="box" id="epi412238-blkfxd-0001" orientation="portrait" position="anchor"><caption><title>Key Points</title></caption><p>
<list id="epi412238-list-0001" list-type="bullet"><list-item><p>This review discusses the progress made in using patient‐induced pluripotent stem cells to study the molecular mechanisms of genetic epilepsies in a subset of patients</p></list-item><list-item><p>iPSC models for most of these diseases have demonstrated altered processes of neuronal excitation and inhibition caused by neurodevelopmental disturbances, ion channel abnormalities, and changes in synaptic functions</p></list-item><list-item><p>In addition, astrocyte activations, mitochondrial dysfunctions, and signaling pathway activations have been observed in some of these disease models</p></list-item></list>
</p></boxed-text>
</p>
<sec id="epi412238-sec-0002">
<p>Genetic epilepsy (GE) is a genetic disease with epileptic seizures as a core symptom that is directly caused by known or presumed genetic defects.<xref ref-type="ref" rid="epi412238-bib-0001">1</xref>, <xref ref-type="ref" rid="epi412238-bib-0002">2</xref>, <xref ref-type="ref" rid="epi412238-bib-0003">3</xref>, <xref ref-type="ref" rid="epi412238-bib-0004">4</xref> Due to ethical constraints, it is impossible to perform experiments on patients or to obtain their brain tissue for research. Research on the molecular mechanisms of GE has therefore been performed almost exclusively in animal models.<xref ref-type="ref" rid="epi412238-bib-0005">5</xref> The differences between humans and animals often prevent animal models from truly reflecting the reasons for the development of epilepsy in humans. Induced pluripotent stem cell (iPSC) technology is creating a new platform for the study of the molecular mechanisms of GE. With this new technology, terminally differentiated cells collected from GE patients who present with specific genetic patterns can be reprogrammed into iPSCs and then differentiated into neuronal subtypes. These cells carry all of a patient's specific genetic information, including its differences from healthy controls. Thus, iPSCs can provide a reliable platform for the study of the molecular mechanisms of GE.<sup>6–25</sup>
</p>
<p>Studies using iPSC technology to investigate the molecular mechanisms of GE have included studies focusing on Rett syndrome, Dravet syndrome, Phelan‐McDermid syndrome (PMDS), and fragile X syndrome (FxS). Classic GE syndromes include childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic–clonic seizures alone (GTCS). A recent study using human genetic screening and animal experiments confirmed that CAE and JAE are associated with multiple combined mutations in T‐type calcium channels and γ‐aminobutyric acid (GABA)<sub>A</sub> receptors rather than single‐gene mutations.<xref ref-type="ref" rid="epi412238-bib-0026">26</xref>, <xref ref-type="ref" rid="epi412238-bib-0027">27</xref>, <xref ref-type="ref" rid="epi412238-bib-0028">28</xref> In addition, gene mutations in several proteins other than ion channels can also cause seizures through spikes in discharges that create abnormal neural circuits in the cortex and thalamus.<xref ref-type="ref" rid="epi412238-bib-0029">29</xref>, <xref ref-type="ref" rid="epi412238-bib-0030">30</xref>, <xref ref-type="ref" rid="epi412238-bib-0031">31</xref> Abnormalities in the frontal cortex and thalamus are the major changes that are observed via imaging of JME.<xref ref-type="ref" rid="epi412238-bib-0032">32</xref> Bilateral thalamic neuron dysfunction and a thinner corpus callosum may be markers of structural brain changes in JME patients compared with GTCS patients.<xref ref-type="ref" rid="epi412238-bib-0033">33</xref>, <xref ref-type="ref" rid="epi412238-bib-0034">34</xref> However, studies on the pathogeneses of CAE, JAE, JME, and GTCS using iPSC technology have not been performed. Here, we review and summarize several recent studies on the molecular mechanisms of GE, with a particular focus on some newly identified mutated genes, such as <italic>MTTK</italic> (thymidine kinase 2, mitochondrial), <italic>PIGA</italic> (phosphatidylinositol <italic>N</italic>‐acetylglucosaminyltransferase subunit A), <italic>STXBP1</italic> (syntaxin‐binding protein 1), <italic>ARHGEF9</italic> (Rho guanine nucleotide exchange factor 9), and <italic>LIS1</italic> (lissencephaly‐1) (Table <xref ref-type="table" rid="epi412238-tbl-0001">1</xref>).</p>
<table-wrap id="epi412238-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Summary of induced pluripotent stem cell studies of genetic epilepsies</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Protein</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease</th>
<th align="left" colspan="1" rowspan="1" valign="top">Findings</th>
<th align="left" colspan="1" rowspan="1" valign="top">Publication(s)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SCN1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">Nav1.1</td>
<td align="left" colspan="1" rowspan="1">
Dravet syndrome<break></break>
GEFS+ICEGTC<break></break>
SMEI
</td>
<td align="left" colspan="1" rowspan="1">Deficits in sodium currents and action potential firing, increased excitatory level of spontaneous postsynaptic activity</td>
<td align="left" colspan="1" rowspan="1">
Liu et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0054">54</xref>
<break></break>
Jiao et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0052">52</xref>
<break></break>
Higurashi et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0036">36</xref>
<break></break>
Liu et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0021">21</xref>
<break></break>
Sun et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0053">53</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1C</italic>
</td>
<td align="left" colspan="1" rowspan="1">Cav1.2</td>
<td align="left" colspan="1" rowspan="1">Timothy syndrome</td>
<td align="left" colspan="1" rowspan="1">Defects in calcium signaling, limited neuronal differentiation</td>
<td align="left" colspan="1" rowspan="1">
Pasca et al. (2011)<xref ref-type="ref" rid="epi412238-bib-0058">58</xref>
<break></break>
Krey et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0059">59</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>MTTK</italic>
</td>
<td align="left" colspan="1" rowspan="1">tRNALys</td>
<td align="left" colspan="1" rowspan="1">MERRF syndrome</td>
<td align="left" colspan="1" rowspan="1">Enhanced mitochondrial autophagy, reduced growth</td>
<td align="left" colspan="1" rowspan="1">
Chou et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0024">24</xref>
<break></break>
Hamalainen et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0062">62</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>STXBP1</italic>
</td>
<td align="left" colspan="1" rowspan="1">STXBP1</td>
<td align="left" colspan="1" rowspan="1">Ohtahara syndrome</td>
<td align="left" colspan="1" rowspan="1">Impairment in synaptic transmission and neurite outgrowth</td>
<td align="left" colspan="1" rowspan="1">
Patzke et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0066">66</xref>
<break></break>
Yamashita et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0067">67</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>SHANK3</italic>
</td>
<td align="left" colspan="1" rowspan="1">SHANK3</td>
<td align="left" colspan="1" rowspan="1">PMDS</td>
<td align="left" colspan="1" rowspan="1">Defects in excitatory synaptic transmission, insulin‐like growth factor 1 (IGF1) can be rescued in some phenotypes</td>
<td align="left" colspan="1" rowspan="1">
Shcheglovitov et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0069">69</xref>
<break></break>
Holder et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0070">70</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>PIGA</italic>
</td>
<td align="left" colspan="1" rowspan="1">PIGA</td>
<td align="left" colspan="1" rowspan="1">MCAHS2</td>
<td align="left" colspan="1" rowspan="1">Decreased proliferation, abnormal membrane depolarization</td>
<td align="left" colspan="1" rowspan="1">Yuan et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0075">75</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>MECP2</italic>
</td>
<td align="left" colspan="1" rowspan="1">MECP2</td>
<td align="left" colspan="1" rowspan="1">Rett syndrome</td>
<td align="left" colspan="1" rowspan="1">Reduces GABAergic neurotransmission, fewer synapses, reduced dendritic arborization and reduced spine density; IGF1 causes neurite improvement that may be related to the thyroid hormone receptor</td>
<td align="left" colspan="1" rowspan="1">
Chen et al. (2018)<xref ref-type="ref" rid="epi412238-bib-0041">41</xref>
<break></break>
Yoo et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0040">40</xref>
<break></break>
de Souza et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0043">43</xref>
<break></break>
Chin et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0042">42</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>CDKL5</italic>
</td>
<td align="left" colspan="1" rowspan="1">CDKL5</td>
<td align="left" colspan="1" rowspan="1">Rett syndrome</td>
<td align="left" colspan="1" rowspan="1">Phosphorylated MECP2, aberrant dendritic spines</td>
<td align="left" colspan="1" rowspan="1">Livide et al. (2015)<xref ref-type="ref" rid="epi412238-bib-0037">37</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>FMR1</italic>
</td>
<td align="left" colspan="1" rowspan="1">FMR1</td>
<td align="left" colspan="1" rowspan="1">FxS</td>
<td align="left" colspan="1" rowspan="1">Impaired methylation of the FMR1 promoter region, defective neurite initiation and extension, increased differentiation of CP‐AMPAR and <italic>N</italic>‐methyl‐<sc>d</sc>‐aspartate (NMDA) receptor‐coexpressing cells lacking GluA2</td>
<td align="left" colspan="1" rowspan="1">
Telias et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0079">79</xref>
<break></break>
Doers et al. (2014)<xref ref-type="ref" rid="epi412238-bib-0080">80</xref>
<break></break>
de Esch et al. (2014)<xref ref-type="ref" rid="epi412238-bib-0081">81</xref>
<break></break>
Halevy et al. (2015)<xref ref-type="ref" rid="epi412238-bib-0083">83</xref>
<break></break>
Lu et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0082">82</xref>
<break></break>
Li et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0111">111</xref>
<break></break>
Achuta et al. (2018)<xref ref-type="ref" rid="epi412238-bib-0084">84</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>UBE3A</italic>
</td>
<td align="left" colspan="1" rowspan="1">UBE3A</td>
<td align="left" colspan="1" rowspan="1">Angelman syndrome, PWS</td>
<td align="left" colspan="1" rowspan="1">Altered resting membrane potential, neuron‐specific long noncoding RNA (lncRNA) ‐ in the silenced paternal UBE3A</td>
<td align="left" colspan="1" rowspan="1">
Chamberlain et al. (2010)<xref ref-type="ref" rid="epi412238-bib-0086">86</xref>
<break></break>
Okunoetal. (2017)<xref ref-type="ref" rid="epi412238-bib-0087">87</xref>
<break></break>
Fink et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0090">90</xref>
<break></break>
Chen et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0090">90</xref>
<break></break>
Stanurova et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0088">88</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17p13.3</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Miller‐Dieker syndrome</td>
<td align="left" colspan="1" rowspan="1">Increased horizontal cell divisions causing a cell migration defect, disturbance of the N‐cadherin/β‐catenin signaling axis</td>
<td align="left" colspan="1" rowspan="1">
Bershteyn et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0013">13</xref>
<break></break>
Iefremova et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0096">96</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>GFAP</italic>
</td>
<td align="left" colspan="1" rowspan="1">GFAP</td>
<td align="left" colspan="1" rowspan="1">Alexander disease</td>
<td align="left" colspan="1" rowspan="1">Increased glutamate neurotransmitter release, nerve activity alterations, neuronal maturation promoted by mature glial cells</td>
<td align="left" colspan="1" rowspan="1">
Tang et al. (2013)<xref ref-type="ref" rid="epi412238-bib-0103">103</xref>
<break></break>
Williams et al. (2014)<xref ref-type="ref" rid="epi412238-bib-0104">104</xref>
<break></break>
Odawata et al. (2014)<xref ref-type="ref" rid="epi412238-bib-0102">102</xref>
<break></break>
Kondo et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0099">99</xref>
<break></break>
Ishii et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0101">101</xref>
<break></break>
Lischka et al. (2018)<xref ref-type="ref" rid="epi412238-bib-0105">105</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>ARHGEF9</italic>
</td>
<td align="left" colspan="1" rowspan="1">CB</td>
<td align="left" colspan="1" rowspan="1">X‐linked intellectual disability with epilepsy</td>
<td align="left" colspan="1" rowspan="1">Disinhibited mTORC1 signaling contributes to the pathologic process</td>
<td align="left" colspan="1" rowspan="1">Machado et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0020">20</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>TSC1/TSC2</italic>
</td>
<td align="left" colspan="1" rowspan="1">Hamartin</td>
<td align="left" colspan="1" rowspan="1">Tuberous sclerosis</td>
<td align="left" colspan="1" rowspan="1">mTORC1 pathway hyper activation, defects in neuronal differentiation, hypoexcitability, and reduced synaptic activity</td>
<td align="left" colspan="1" rowspan="1">
Sundberg et al. (2018)<xref ref-type="ref" rid="epi412238-bib-0112">112</xref>
<break></break>
Li et al. (2017)<xref ref-type="ref" rid="epi412238-bib-0111">111</xref>
<break></break>
Ebrahimi‐Fakhari et al. (2016)<xref ref-type="ref" rid="epi412238-bib-0110">110</xref>
<break></break>
Ebrahimi‐Fakhari et al. (2015)<xref ref-type="ref" rid="epi412238-bib-0109">109</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="epi412238-note-0002">
<p>AMPA, α‐amino‐3‐hydroxy‐5‐methyl‐4‐boxazolepropionate acid; FxS, fragile X syndrome; GEFS+, mild inherited disorder generalized epilepsy with febrile seizures plus; GFAP, glial fibrillary acidic protein; ICEGTC, intractable childhood epilepsy with generalized tonic–clonic seizures; MERRF, myoclonic epilepsy associated with ragged‐red fibers; MCAHS2, multiple congenital anomalies‐hypotonia‐seizure syndrome 2; NMDA, <italic>N</italic>‐methyl‐<sc>d</sc>‐aspartic acid receptor; PMDS, Phelan‐McDermid syndrome; PWS, Prader‐Willi syndrome; SMEI, severe myoclonic epilepsy in infancy; tRNALys, mitochondrial transfer RNA for lysine.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="epi412238-sec-0003">
<title>Development of iPSC Technology</title>
<p>In 2006, Takahashi et al.<xref ref-type="ref" rid="epi412238-bib-0035">35</xref> first proposed the concept of iPSCs. The authors introduced 4 transcription factors into fibroblasts obtained from a rat and a human patient and successfully reprogrammed the fibroblasts into iPSCs. Next, Higurashi et al.<xref ref-type="ref" rid="epi412238-bib-0036">36</xref> used this technology to study a patient with Dravet syndrome, which is characterized by refractory seizures. The authors differentiated the iPSCs into neurons and, using electrophysiologic techniques, detected weak action potentials in inhibitory neurons. Subsequently, Livide et al.<xref ref-type="ref" rid="epi412238-bib-0037">37</xref> induced different iPSCs from the cells of a patient with Rett syndrome carrying a methylated CpG‐binding protein 2 gene (<italic>MECP2</italic>) mutation (p.Arg306Cys) and from the cells of 2 patients with Rett syndrome carrying cell cycle–dependent kinase‐like protein 5 gene (<italic>CDKL5</italic>) mutations (p.Gln347Ter and p.Thr288Ile) and from the cells of one healthy control. These researchers found that these mutations downregulated the ionic glutamate receptor D1 (GluD1), which is known as a synaptic adhesion molecule that maintains normal presynaptic and postsynaptic membrane stabilities.<xref ref-type="ref" rid="epi412238-bib-0038">38</xref>, <xref ref-type="ref" rid="epi412238-bib-0039">39</xref> Some subsequent studies have suggested that an <italic>MECP2</italic> mutation decreases neuron size and synapse number and affects the differentiation of glutamatergic neurons.<xref ref-type="ref" rid="epi412238-bib-0040">40</xref>, <xref ref-type="ref" rid="epi412238-bib-0041">41</xref>, <xref ref-type="ref" rid="epi412238-bib-0042">42</xref> These abnormal phenotypes can be alleviated by using insulin‐like growth factor 1 (IGF1), which interacts with IGF1/IGF1R and thyroid hormone receptor (TRalpha 3).<xref ref-type="ref" rid="epi412238-bib-0043">43</xref> Thus, iPSC technology has created favorable conditions for the direct study of the molecular mechanisms of human GE.</p>
</sec>
<sec id="epi412238-sec-0004">
<title>iPSC Studies on the Molecular Mechanisms of GE</title>
<sec id="epi412238-sec-0005">
<title>Influence of the transmembrane motion of ions</title>
<p>The normal transmembrane movement of ions is the main factor that generates and maintains the action potential and the resting membrane potential of neurons. Abnormal ion channels can lead to abnormal transmembrane movement of ions and serve as the basis of seizures.</p>
<sec id="epi412238-sec-0006">
<title>Voltage‐gated sodium channel abnormalities</title>
<p>Many subtypes of voltage‐gated sodium channels (Nav) have been identified, and each channel consists of a large α subunit and 2 small β subunits.<xref ref-type="ref" rid="epi412238-bib-0044">44</xref> Mutations in the genes <italic>SCN1A</italic> (encoding Nav1.1), <italic>SCN2A</italic> (encoding Nav1.2), <italic>SCN3A</italic> (encoding Nav1.3), <italic>SCN8A</italic> (encoding Nav1.6), <italic>SCN9A</italic> (encoding Nav1.7), and <italic>SCN1B</italic> (encoding Navβ1) produce abnormal voltage‐gated sodium channels and are associated with epilepsy.<xref ref-type="ref" rid="epi412238-bib-0045">45</xref>, <xref ref-type="ref" rid="epi412238-bib-0046">46</xref> Nav1.1 is expressed at high levels in the central nervous system, and <italic>SCN1A</italic> mutations, of which there are more than 1,257 types, cause various types of epilepsy.<xref ref-type="ref" rid="epi412238-bib-0047">47</xref> Ten percent of <italic>SCN1A</italic> mutations on chromosome 2 are associated with generalized epilepsy and febrile seizures plus (GEFS+).<xref ref-type="ref" rid="epi412238-bib-0048">48</xref>, <xref ref-type="ref" rid="epi412238-bib-0049">49</xref>, <xref ref-type="ref" rid="epi412238-bib-0050">50</xref>
<italic>SCN1A</italic> mutations cause approximately 85% of Dravet syndrome cases, which are characterized by intractable infantile seizures and cognitive impairment.<xref ref-type="ref" rid="epi412238-bib-0051">51</xref> Using an iPSC technique, Jiao et al.<xref ref-type="ref" rid="epi412238-bib-0052">52</xref> studied Dravet syndrome patients with <italic>SCN1A</italic> (F1415I) mutations and GEFS+ patients with <italic>SCN1A</italic> (Q1923R) mutations and found that the glutamatergic neurons derived from both types of patients exhibited hyperexcitability. The sodium currents and action potentials in the glutamatergic neurons from the Dravet syndrome patients were stronger than those from the GEFS+ patients, which is consistent with the severity of the clinical seizures in the 2 conditions. However, several subsequent studies using iPSCs combined with CRISPR/Cas9 gene repair techniques, and neuron‐specific fluorescence labeling techniques confirmed that <italic>SCN1A</italic> gene mutations are more likely to cause reduced inhibition throughout the neural network by weakening the activity of interneurons.<xref ref-type="ref" rid="epi412238-bib-0021">21</xref>, <xref ref-type="ref" rid="epi412238-bib-0026">26</xref>, <xref ref-type="ref" rid="epi412238-bib-0053">53</xref> Moreover, until a later period of differentiation, the sodium ion currents, action potential thresholds, and spontaneous discharge frequencies in these 2 conditions were demonstrated to differ from those of healthy controls. The overactivation of sodium channels leads to enhanced neuronal activity, which leads to network hyperexcitability.<xref ref-type="ref" rid="epi412238-bib-0054">54</xref>
</p>
</sec>
<sec id="epi412238-sec-0007">
<title>Voltage‐gated calcium channel abnormalities</title>
<p>Niemann‐Pick type C (NPC1) is a rare progressive neurodegenerative disease that presents with cerebellar atrophy, decreased cognitive abilities, and severe epilepsy. Children generally die within 1–2 years after onset.<xref ref-type="ref" rid="epi412238-bib-0055">55</xref> Electrophysiologic examinations have revealed attenuated calcium‐mediated currents in induced neurons and reduced voltage‐gated ion channel activity.<xref ref-type="ref" rid="epi412238-bib-0056">56</xref>
</p>
<p>A mutation in the fragile X mental retardation 1 gene (<italic>FMR1</italic>), which is on the X chromosome and encodes a multifunctional polyribosome‐associated RNA‐binding protein (FMRP), is found in FxS patients with mental retardation and seizures. Liu et al.<xref ref-type="ref" rid="epi412238-bib-0057">57</xref> detected fewer synapses, reduced expression of the excitatory postsynaptic marker PSD95, reduced synaptic puncta density and neurite length, and increased frequencies and amplitudes of the evoked currents in these differentiated neurons, all of which could be rescued by a calcium channel blocker. These findings indicate that calcium channel abnormalities are the cause of the abnormal morphologies of neurons derived from iPSCs with mutations in <italic>FMR1</italic>.</p>
<p>Mutations in the <italic>CACNA1C</italic> gene encoding the L‐type voltage‐gated calcium channel (Cav1.2) leads to Timothy syndrome, which is characterized by long‐QT syndrome (LQTS), epilepsy, and autism.<xref ref-type="ref" rid="epi412238-bib-0005">5</xref> Compared with normal controls, abnormal current signals induced by calcium ions in iPSCs derived from these patients have been observed, and neuronal differentiation is limited. The abnormal discharge activity of the neurons and RhoA signaling pathway hyperactivity could be rescued by the L‐type calcium channel blocker nimodipine. Channel abnormalities may be one of the important pathogenic mechanisms that lead to nervous system disease with epilepsy.<xref ref-type="ref" rid="epi412238-bib-0058">58</xref>, <xref ref-type="ref" rid="epi412238-bib-0059">59</xref>, <xref ref-type="ref" rid="epi412238-bib-0060">60</xref>
</p>
</sec>
</sec>
<sec id="epi412238-sec-0008">
<title>Mutations affecting mitochondrial function</title>
<p>Mitochondrial DNA mutations are a common cause of nervous system diseases, but the molecular mechanisms are unclear. In 1991, Noer et al.<xref ref-type="ref" rid="epi412238-bib-0061">61</xref> found that mutations in the mitochondrial gene <italic>MTTK</italic>, which encodes the mitochondrial transfer RNA for lysine (tRNALys), cause the genetic disease myoclonic epilepsy associated with ragged‐red fibers (MERRF) syndrome, which occurs in children aged 5–15 years and is characterized by muscle spasms, seizures, and ataxia. Chou et al.<xref ref-type="ref" rid="epi412238-bib-0024">24</xref> studied the possible mechanisms of this disease and found that <italic>MTTK</italic> mutations can lead to decreased oxygen consumption, increased reactive oxygen species (ROS) generation, slower cell growth, and abnormal mitochondrial morphology in iPSCs derived from patients with MERRF syndrome. Furthermore, derived neural precursor cells also display mitochondrial dysfunction, increased ROS generation, and upregulated antioxidant gene expression levels. Hamalainen et al.<xref ref-type="ref" rid="epi412238-bib-0062">62</xref> further explored the mechanism of epilepsy caused by abnormal mitochondrial function. These authors found that respiratory chain complex I was degraded by autophagy mediated by PTEN kinase 1 (PINK1) and Parkin. Mitochondrial autophagy has been suggested to play an important role in the pathogenesis of mitochondrial encephalopathy complicating GE.</p>
</sec>
<sec id="epi412238-sec-0009">
<title>Mutations affecting neuronal development</title>
<p>Neuronal development includes the maturation of neurites and neuronal migration.<xref ref-type="ref" rid="epi412238-bib-0063">63</xref> Structural changes in and dysfunctions of neurites and abnormal migration during the neuronal development period will generate dysplastic neurons,<xref ref-type="ref" rid="epi412238-bib-0064">64</xref> and this process is an important factor in the generation of epilepsy.</p>
<sec id="epi412238-sec-0010">
<title>Mutations affecting neurite maturation</title>
<p>Mutations in <italic>STXBP1</italic>, the gene that encodes syntaxin‐binding protein 1 (STXBP1), can lead to various types of seizures.<xref ref-type="ref" rid="epi412238-bib-0065">65</xref> Patzke et al.<xref ref-type="ref" rid="epi412238-bib-0066">66</xref> used gene knockout combined with Cre/Lox and optogenetic techniques to achieve the targeted knockout of <italic>STXBP1</italic> gene expression in neurons from healthy human‐derived iPSCs and found that the mutant neurons exhibited a 50% reduction in synaptic transmission. Subsequently, another group studied iPSCs from patients with Ohtahara syndrome with <italic>STXBP1</italic> mutations (c.1099C&gt;T; p.R367X), characterized by frequent tonic seizures and burst‐suppression electroencephalograms in infancy. The levels of the transcription and protein expression of <italic>STXBP1</italic> in the mutated iPSC neurons were reduced by 50% compared with the levels in the induced neurons in the controls, and the growth of neurites was significantly decreased.<xref ref-type="ref" rid="epi412238-bib-0067">67</xref> These results suggested that <italic>STXBP1</italic> gene mutations affect neurite growth and synaptic transmission.</p>
<p>Phelan‐McDermid Syndrome, which is characterized mainly by seizures, mental retardation, and language disorders, can be caused by the deletion mutation 22q13.3 in the <italic>SHANK3</italic> gene, which encodes an excitatory postsynaptic scaffolding protein.<xref ref-type="ref" rid="epi412238-bib-0068">68</xref> Shcheglovitov et al.<xref ref-type="ref" rid="epi412238-bib-0069">69</xref> generated iPSCs from individuals with PMDS and autism and used them to produce functional neurons. These authors found that the <italic>SHANK3</italic> mutation could lead not only to decreased synaptic transmission but also to abnormal excitatory synapses with downregulation of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid (AMPA) and <italic>N</italic>‐methyl‐<sc>d</sc>‐aspartate (NMDA) receptors. Gene repair or IGF1 interventions can restore excitatory synaptic transmission. It has been suggested that deletions in the <italic>SHANK3</italic> gene could possibly mediate the mechanism of epileptic seizures by causing a decrease in excitatory synaptic function.<xref ref-type="ref" rid="epi412238-bib-0070">70</xref>, <xref ref-type="ref" rid="epi412238-bib-0071">71</xref>, <xref ref-type="ref" rid="epi412238-bib-0072">72</xref>, <xref ref-type="ref" rid="epi412238-bib-0073">73</xref>
</p>
<p>Multiple congenital anomalies‐hypotonia‐seizures syndrome 2 (MCAHS2), characterized by epilepsy, myoclonus, and mental retardation,<xref ref-type="ref" rid="epi412238-bib-0074">74</xref> can be caused by mutations in another membrane protein gene, the phosphatidylinositol glycan class A gene (<italic>PIGA</italic>), which encodes a phosphatidylinositol glycan class A protein (PIGA), one of the phospholipid elements of the cell membrane. Yuan et al.<xref ref-type="ref" rid="epi412238-bib-0075">75</xref> found that iPSCs from patients with <italic>PIGA</italic> mutations (c.1234C&gt;T) exhibit lower proliferative capacity than normal heterozygotes, fewer induced GABAergic neurons with low maturation levels, aberrant synapse formation, and abnormal membrane depolarization. These results suggest that mutations in the <italic>PIGA</italic> gene may lead to the development of MCAHS2 by reducing inhibitory synaptic function.</p>
<p>The <italic>FMR1</italic> gene encodes a ribosome‐associated mRNA‐binding protein (FMRP) that is involved in regulating the transcriptional efficiency of the target gene, but an expansion of CGG repeats in a region of the gene leads to <italic>FMR1</italic> silencing.<xref ref-type="ref" rid="epi412238-bib-0076">76</xref> Patient‐derived neurons display defective neurite initiation and extension, reduced synaptic function, reduced synapse number, and reduced expression of the excitatory postsynaptic marker PSD95.<xref ref-type="ref" rid="epi412238-bib-0077">77</xref>, <xref ref-type="ref" rid="epi412238-bib-0078">78</xref>, <xref ref-type="ref" rid="epi412238-bib-0079">79</xref>, <xref ref-type="ref" rid="epi412238-bib-0080">80</xref> Subsequently, de Esch et al.<xref ref-type="ref" rid="epi412238-bib-0081">81</xref> confirmed that hypermethylation of the <italic>FMR1</italic> gene promoter leads to the absence of FMRP and that demethylation could significantly rescue neural cell development. <italic>FMR1</italic> gene silencing also leads to transcriptional changes in neuronal differentiation‐related genes (i.e., <italic>WNT1, BMP4, POU3F4, TFAP2C,</italic> and <italic>PAX3</italic>) and synapse‐related protein genes (i.e., <italic>SHANK1</italic> and <italic>NNAT</italic>).<xref ref-type="ref" rid="epi412238-bib-0082">82</xref> The inhibition of RE‐1 silencing transcription factor (REST) induces the upregulation of many of these related genes.<xref ref-type="ref" rid="epi412238-bib-0083">83</xref> These results demonstrate that <italic>FMR1</italic> gene silencing affects various protein molecules that are involved in neurodevelopment, thereby causing disorders in neuronal axon growth and synapse formation. A recent study found that <italic>FMR1</italic> mutations lead to decreased expression of GluA2 in AMPA receptors in patient‐derived neurons, yielding increased proportions of calcium‐permeable AMPAR‐ and NMDA receptor–coexpressing cells with an abnormal increase in the calcium current.<xref ref-type="ref" rid="epi412238-bib-0084">84</xref> These alterations may be important bases for seizures because <italic>FMR1</italic> silencing causes synaptic dysplasia, abnormal excitatory synaptic receptor expression, and neural network hyperactivity.</p>
<p>Angelman syndrome (AS) is a type of maternally inherited disease that is characterized by severe developmental delay, pleasant affect, and epileptic seizures. The causative gene <italic>UBE3A</italic>, located on chromosome 15q11.2‐q13, encodes ubiquitin protein ligase E3.<xref ref-type="ref" rid="epi412238-bib-0085">85</xref> Deletion mutations in the same region of the paternal‐origin chromosome lead to Prader‐Willi syndrome (PWS). Hypermethylation of chromosome 15q11.2‐q13 is present in all patients. Therefore, hypermethylation of the <italic>UBE3A</italic> gene has previously been considered the main cause of these diseases. However, hypermethylation has not been obvious in iPSC studies.<xref ref-type="ref" rid="epi412238-bib-0086">86</xref>, <xref ref-type="ref" rid="epi412238-bib-0087">87</xref> Changes in the <italic>UBE3A</italic> gene affect the functional maturation of neurons, and the appearance of AMPA receptor–mediated excitatory postsynaptic currents (EPSCs) in patient‐derived neurons is significantly delayed.<xref ref-type="ref" rid="epi412238-bib-0088">88</xref> In the late stage of neuronal development and maturation, the resting membrane potential exhibits depolarization, decreased spontaneous excitatory postsynaptic action potentials, decreased neuron activity, and decreased synaptic plasticity. In combination with the CRISPR/Cas9 gene‐editing technique, it was demonstrated that the depolarization of the resting membrane potential induced by the <italic>UBE3A</italic> mutation might be an important cause of altered cell activity.<xref ref-type="ref" rid="epi412238-bib-0089">89</xref> Chen et al.<xref ref-type="ref" rid="epi412238-bib-0090">90</xref> explored the underlying pathophysiology using iPSC‐derived neurons from patients with Angelman syndrome and unaffected controls and found that the long noncoding RNAs (lncRNAs) RNA‐binding protein fox‐1 homolog (RBFOX1) and RBFOX2 were downregulated in Angelman syndrome neurons. When UBE3A was overexpressed, the differentiation abnormalities in the immature cells were rescued. These results suggested that the deletion of these lncRNAs was a key reason for the abnormal differentiation of immature cells caused by <italic>UBE3A</italic> gene mutation.</p>
</sec>
<sec id="epi412238-sec-0011">
<title>Mutations affecting neuronal migration</title>
<p>Miller‐Dieker syndrome, characterized by the clinical manifestations of mental retardation and intractable epilepsy, is associated with 17p13.3 heterozygous deletion mutations. This 17p13.3 region includes the gene <italic>LIS1</italic>, which participates in neural migration, and the gene <italic>YWHAE,</italic> which binds with a phosphoserine on another interacting protein.<xref ref-type="ref" rid="epi412238-bib-0091">91</xref>, <xref ref-type="ref" rid="epi412238-bib-0092">92</xref> Loss of 17p13.3 leads to increased iPSC apoptosis, delayed cell migration, and abnormal mitosis of the primate‐specific outer radial glial cells, which decreases the expression of the normal properties of radial glial cells during cortical development.<xref ref-type="ref" rid="epi412238-bib-0013">13</xref>, <xref ref-type="ref" rid="epi412238-bib-0093">93</xref> Some studies have demonstrated that the quality and proliferation properties of outer radial glial cells are critical to the process of cortical neuron migration.<xref ref-type="ref" rid="epi412238-bib-0094">94</xref>, <xref ref-type="ref" rid="epi412238-bib-0095">95</xref> Recent studies have demonstrated that asymmetrical cell division and the proliferation of radial glial cells cause cortical neuron migration disturbances that might be related to changes in the structure of microtubule networks and the destruction of cortical marginal structures found in morphologic observations of pathologic patient‐derived brain tissue. Regulating the dysfunction of outer radial glial cells could rescue the mitotic abnormalities and neural cortex development disorders.<xref ref-type="ref" rid="epi412238-bib-0096">96</xref> These studies indicated that migration disorders play an important role in the pathogenesis of GE.<xref ref-type="ref" rid="epi412238-bib-0097">97</xref> The abnormalities in the primate‐specific outer radial glial cells that may play a key role in the pathogenesis of Miller‐Dieker syndrome cannot be observed in animal models. Therefore, iPSC technology may provide a reliable platform for direct investigations of the neuronal migration disorder mechanisms associated with the pathogenesis of human GE.</p>
</sec>
</sec>
<sec id="epi412238-sec-0012">
<title>Mutations affecting glial cell activation</title>
<p>Patients with Alexander disease (AxD), associated with mutations in the glial fibrillary acidic protein gene (<italic>GFAP</italic>), develop a leukoencephalopathy with macrocephaly, seizures, and psychomotor retardation, which usually leads to death within the first decade.<xref ref-type="ref" rid="epi412238-bib-0098">98</xref> Kondo et al.<xref ref-type="ref" rid="epi412238-bib-0099">99</xref> found that GFAP accumulates locally in patient‐derived glial cells, the Rosenthal‐fiber‐like structure in the intracellular area becomes entangled, and there are increases in N‐cadherin expression, mammalian target of rapamycin (mTOR) signaling pathway activity, and the release of cytokine and glutamate neurotransmitters.<xref ref-type="ref" rid="epi412238-bib-0100">100</xref> Recently, Ishii et al.<xref ref-type="ref" rid="epi412238-bib-0101">101</xref> used iPSCs combined with single‐cell RNA transcription analysis technology and found that iPSC‐induced glial cells can enhance the activities of AMPA and NMDA receptors in excitatory neurons<xref ref-type="ref" rid="epi412238-bib-0102">102</xref> and increase their high‐frequency spontaneous discharges.<xref ref-type="ref" rid="epi412238-bib-0103">103</xref> Other studies also found that glial cells can increase the excitatory field potentials and spontaneous synaptic discharge frequencies of neurons that are differentiated from co‐cultured iPSCs. Thus, enhanced glial cell activity may be involved in epileptic seizures by increasing intracellular signal activation and glial‐neural network excitability. A similar phenomenon was found in iPSC‐derived astrocytes from Rett syndrome patients; patient‐derived astrocytes were able to induce abnormal differentiation and reduce the axon lengths and synapse numbers of co‐cultured interneurons. Simultaneously, healthy‐control–derived glial cells could effectively improve the axon length and synapse number in co‐cultured interneurons derived from patients with Rett syndrome, which suggests that glial cells may affect synapse formation in neurons through non–cell‐autonomous effects from astrocytes.<xref ref-type="ref" rid="epi412238-bib-0104">104</xref> A recent study found that only mature, differentiated glial cells could maintain spontaneous neuronal electrical activity.<xref ref-type="ref" rid="epi412238-bib-0105">105</xref> Studies have demonstrated that glial cell disorders caused by genetic mutations play an important role in unbalanced excitability in the nervous circuit.<xref ref-type="ref" rid="epi412238-bib-0106">106</xref>
</p>
</sec>
<sec id="epi412238-sec-0013">
<title>Signaling pathway abnormalities</title>
<p>The mammalian target of rapamycin complex‐1 (mTORC1) signaling pathway plays an important role in the development and maintenance of normal nervous system function. Activation of the mTORC1 signaling pathway results in a decrease in the aggregation of inhibitory GABA<sub>A</sub> receptors on the postsynaptic membrane and a decrease in the number of inhibitory synapses.<xref ref-type="ref" rid="epi412238-bib-0107">107</xref> Mutation of the collybistin protein (CB) gene (<italic>ARHGEF9</italic>) reduces GABAergic neurotransmission, affects synaptic plasticity, and results in several nervous system diseases, such as epilepsy, anxiety disorders, and autism.<xref ref-type="ref" rid="epi412238-bib-0108">108</xref> Machado et al.<xref ref-type="ref" rid="epi412238-bib-0020">20</xref> collected fibroblasts from patients with X‐linked intellectual disability with epilepsy due to mutations in the CB gene and reprogrammed them into iPSCs that were differentiated into neural precursor cells. These researchers found that the CB protein forms a complex with mTOR under normal circumstances and negatively regulates the activity of the mTORC1 signaling pathway. Neurons derived from cells with <italic>ARHGEF9</italic> mutations showed abnormal phosphorylation and increased activity of the mTOR‐signaling pathway. Aberrant activation of the mTOR‐signaling pathway has been detected in differentiated neural cells and astrocytes derived from patients with mutations in tuberous sclerosis complex genes (<italic>TSC1</italic> or <italic>TSC2</italic>), which encode tuberous sclerosis complex proteins, causing tuberous sclerosis.<xref ref-type="ref" rid="epi412238-bib-0109">109</xref> The mitochondrial autophagy observed in these mutated cells caused decreased mitochondrial axonal and global turnover and impaired mitochondrial metabolism.<xref ref-type="ref" rid="epi412238-bib-0110">110</xref> Decreased expression of synaptic receptors and synaptic proteins has been observed.<xref ref-type="ref" rid="epi412238-bib-0111">111</xref> A recent study revealed that the gene mutation resulted in synaptic dysfunction, a decrease in glutamate receptor delta 2 (GRID2), and hypoexcitability of Purkinje cells derived from iPSCs from TSC patients. These dysfunctions were rescued with the mTORC1 pathway inhibitor rapamycin.<xref ref-type="ref" rid="epi412238-bib-0112">112</xref> These results suggest that the hyperactivity of this signaling pathway may impair mitochondrial metabolism and neuronal development and alter nerve excitability.<xref ref-type="ref" rid="epi412238-bib-0113">113</xref>
</p>
</sec>
</sec>
<sec id="epi412238-sec-0014">
<title>Conclusion</title>
<p>Using induced pluripotent stem cells (iPSCs), we have reviewed ongoing research to characterize disease mechanisms in genetic epilepsies. In general, genetic dysfunctions can be divided into several categories, including changes in neuronal morphology and neural‐electrophysiologic dysfunction. In addition, mitochondrial autophagy and disturbances to signaling pathways can also be found in some of these disease models. Consequently, these dysfunctions are suggested to affect the excitation/inhibition balance in the neural network. However, many of these studies, such as those addressing the genes <italic>PIGA</italic> and <italic>ARHGEF9</italic>, are single studies and need to be replicated. Given the astonishing pace of advances in the iPSC field since its introduction, use of iPSCs for better understanding the mechanisms of human genetic epilepsies, identifying novel drugs, and developing cell‐based epilepsy therapies seems viable.</p>
</sec>
<sec id="epi412238-sec-0015">
<title>Disclosure</title>
<p>None of the authors has any conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p>
</sec>
</body>
<back>
<bio id="epi412238-biog-0001">
<p>
<bold>Ruijiao Zhou</bold> is a neurologist and PhD student at Chongqing Key Laboratory of Neurology, Chongqing, China.</p>
<graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="EPI4-3-331-g001.gif"></graphic>
</bio>
<ref-list content-type="cited-references" id="epi412238-bibl-0001">
<title>References</title>
<ref id="epi412238-bib-0001">
<label>1</label>
<mixed-citation id="epi412238-cit-0001" publication-type="journal">
<string-name>
<surname>Kwan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Arzimanoglou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Berg</surname>
<given-names>AT</given-names>
</string-name>, et al. <article-title>Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies</article-title>. <source xml:lang="en"/>Epilepsia
<year>2010</year>;<volume>6</volume>:<fpage>1069</fpage>–<lpage>1077</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0002">
<label>2</label>
<mixed-citation id="epi412238-cit-0002" publication-type="journal">
<string-name>
<surname>Berg</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Brodie</surname>
<given-names>MJ</given-names>
</string-name>, et al. <article-title>Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009</article-title>. <source xml:lang="en"/>Epilepsia
<year>2010</year>;<volume>4</volume>:<fpage>676</fpage>–<lpage>685</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0003">
<label>3</label>
<mixed-citation id="epi412238-cit-0003" publication-type="journal">
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Capovilla</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology</article-title>. <source xml:lang="en"/>Epilepsia
<year>2017</year>;<volume>4</volume>:<fpage>512</fpage>–<lpage>521</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0004">
<label>4</label>
<mixed-citation id="epi412238-cit-0004" publication-type="journal">
<string-name>
<surname>Tekgul</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Gencpinar</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Cavusoglu</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population</article-title>. <source xml:lang="en"/>Seizure
<year>2016</year>;<volume>36</volume>:<fpage>16</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">26874856</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0005">
<label>5</label>
<mixed-citation id="epi412238-cit-0005" publication-type="journal">
<string-name>
<surname>Tidball</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Parent</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Concise review: exciting cells: modeling genetic epilepsies with patient‐derived induced pluripotent stem cells</article-title>. <source xml:lang="en"/>Stem Cells
<year>2016</year>;<volume>1</volume>:<fpage>27</fpage>–<lpage>33</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0006">
<label>6</label>
<mixed-citation id="epi412238-cit-0006" publication-type="journal">
<string-name>
<surname>Helmstaedter</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Loer</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wohlfahrt</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>The effects of cognitive rehabilitation on memory outcome after temporal lobe epilepsy surgery</article-title>. <source xml:lang="en"/>Epilepsy Behav
<year>2008</year>;<volume>3</volume>:<fpage>402</fpage>–<lpage>409</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0007">
<label>7</label>
<mixed-citation id="epi412238-cit-0007" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Giri</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Genetic and epigenetic mechanisms of epilepsy: a review</article-title>. <source xml:lang="en"/>Neuropsychiatr Dis Treat
<year>2017</year>;<volume>13</volume>:<fpage>1841</fpage>–<lpage>1859</lpage>.<pub-id pub-id-type="pmid">28761347</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0008">
<label>8</label>
<mixed-citation id="epi412238-cit-0008" publication-type="journal">
<string-name>
<surname>Guella</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>McKenzie</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>DM</given-names>
</string-name>, et al. <article-title>De novo mutations in YWHAG cause early‐onset epilepsy</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>2017</year>;<volume>2</volume>:<fpage>300</fpage>–<lpage>310</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0009">
<label>9</label>
<mixed-citation id="epi412238-cit-0009" publication-type="journal">
<string-name>
<surname>Howard</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Baraban</surname>
<given-names>SC</given-names>
</string-name>. <article-title>Catastrophic epilepsies of childhood</article-title>. <source xml:lang="en"/>Annu Rev Neurosci
<year>2017</year>;<volume>40</volume>:<fpage>149</fpage>–<lpage>166</lpage>.<pub-id pub-id-type="pmid">28772100</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0010">
<label>10</label>
<mixed-citation id="epi412238-cit-0010" publication-type="journal">
<string-name>
<surname>Berg</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Coryell</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Saneto</surname>
<given-names>RP</given-names>
</string-name>, et al. <article-title>Early‐life epilepsies and the emerging role of genetic testing</article-title>. <source xml:lang="en"/>JAMA Pediatr
<year>2017</year>;<volume>171</volume>:<fpage>863</fpage>–<lpage>871</lpage>.<pub-id pub-id-type="pmid">28759667</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0011">
<label>11</label>
<mixed-citation id="epi412238-cit-0011" publication-type="journal">
<string-name>
<surname>Venugopal</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chandanala</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Prasad</surname>
<given-names>HC</given-names>
</string-name>, et al. <article-title>Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies</article-title>. <source xml:lang="en"/>J Tissue Eng Regen Med
<year>2017</year>;<volume>2</volume>:<fpage>321</fpage>–<lpage>333</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0012">
<label>12</label>
<mixed-citation id="epi412238-cit-0012" publication-type="journal">
<string-name>
<surname>Maljevic</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Reid</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Petrou</surname>
<given-names>S</given-names>
</string-name>. <article-title>Models for discovery of targeted therapy in genetic epileptic encephalopathies</article-title>. <source xml:lang="en"/>J Neurochem
<year>2017</year>;<volume>143</volume>:<fpage>30</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">28742937</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0013">
<label>13</label>
<mixed-citation id="epi412238-cit-0013" publication-type="journal">
<string-name>
<surname>Bershteyn</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nowakowski</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Pollen</surname>
<given-names>AA</given-names>
</string-name>, et al. <article-title>Human iPSC‐derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial glia</article-title>. <source xml:lang="en"/>Cell Stem Cell
<year>2017</year>;<volume>4</volume>:<fpage>435</fpage>–<lpage>449</lpage> e434.</mixed-citation>
</ref>
<ref id="epi412238-bib-0014">
<label>14</label>
<mixed-citation id="epi412238-cit-0014" publication-type="journal">
<string-name>
<surname>Upadhya</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hattiangady</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shetty</surname>
<given-names>GA</given-names>
</string-name>, et al. <article-title>Neural stem cell or human induced pluripotent stem cell‐derived GABA‐ergic progenitor cell grafting in an animal model of chronic temporal lobe epilepsy</article-title>. <source xml:lang="en"/>Curr Protoc Stem Cell Biol
<year>2016</year>;<volume>38</volume>:<fpage>2D 7 1</fpage>–<lpage>2D 7 47</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0015">
<label>15</label>
<mixed-citation id="epi412238-cit-0015" publication-type="journal">
<string-name>
<surname>Shi</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Conversion of fibroblasts to parvalbumin neurons by one transcription factor, Ascl1, and the chemical compound forskolin</article-title>. <source xml:lang="en"/>J Biol Chem
<year>2016</year>;<volume>26</volume>:<fpage>13560</fpage>–<lpage>13570</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0016">
<label>16</label>
<mixed-citation id="epi412238-cit-0016" publication-type="journal">
<string-name>
<surname>Schutte</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Schutte</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Barragan</surname>
<given-names>EV</given-names>
</string-name>, et al. <article-title>Model systems for studying cellular mechanisms of SCN1A‐related epilepsy</article-title>. <source xml:lang="en"/>J Neurophysiol
<year>2016</year>;<volume>4</volume>:<fpage>1755</fpage>–<lpage>1766</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0017">
<label>17</label>
<mixed-citation id="epi412238-cit-0017" publication-type="journal">
<string-name>
<surname>Rolfe</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Bosco</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells</article-title>. <source xml:lang="en"/>Cell Biosci
<year>2016</year>;<volume>6</volume>:<fpage>42</fpage>.<pub-id pub-id-type="pmid">27293547</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0018">
<label>18</label>
<mixed-citation id="epi412238-cit-0018" publication-type="journal">
<string-name>
<surname>Odawara</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Katoh</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Matsuda</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Physiological maturation and drug responses of human induced pluripotent stem cell‐derived cortical neuronal networks in long‐term culture</article-title>. <source xml:lang="en"/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>26181</fpage>.<pub-id pub-id-type="pmid">27188845</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0019">
<label>19</label>
<mixed-citation id="epi412238-cit-0019" publication-type="journal">
<string-name>
<surname>Maeda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chiyonobu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome</article-title>. <source xml:lang="en"/>J Hum Genet
<year>2016</year>;<volume>6</volume>:<fpage>565</fpage>–<lpage>569</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0020">
<label>20</label>
<mixed-citation id="epi412238-cit-0020" publication-type="journal">
<string-name>
<surname>Machado</surname>
<given-names>CO</given-names>
</string-name>, <string-name>
<surname>Griesi‐Oliveira</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Rosenberg</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Collybistin binds and inhibits mTORC1 signaling: a potential novel mechanism contributing to intellectual disability and autism</article-title>. <source xml:lang="en"/>Eur J Hum Genet
<year>2016</year>;<volume>1</volume>:<fpage>59</fpage>–<lpage>65</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0021">
<label>21</label>
<mixed-citation id="epi412238-cit-0021" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>CRISPR/Cas9 facilitates investigation of neural circuit disease using human iPSCs: mechanism of epilepsy caused by an SCN1A loss‐of‐function mutation</article-title>. <source xml:lang="en"/>Transl Psychiatry
<year>2016</year>;<volume>6</volume>:<fpage>e703</fpage>.<pub-id pub-id-type="pmid">26731440</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0022">
<label>22</label>
<mixed-citation id="epi412238-cit-0022" publication-type="journal">
<string-name>
<surname>Kruger</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Isom</surname>
<given-names>LL</given-names>
</string-name>. <article-title>Voltage‐gated Na+ channels: not just for conduction</article-title>. <source xml:lang="en"/>Cold Spring Harb Perspect Biol
<year>2016</year>;<volume>8</volume>:<fpage>pii: a029264</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0023">
<label>23</label>
<mixed-citation id="epi412238-cit-0023" publication-type="journal">
<string-name>
<surname>Compagnucci</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Piermarini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sferra</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Cytoskeletal dynamics during in vitro neurogenesis of induced pluripotent stem cells (iPSCs)</article-title>. <source xml:lang="en"/>Mol Cell Neurosci
<year>2016</year>;<volume>77</volume>:<fpage>113</fpage>–<lpage>124</lpage>.<pub-id pub-id-type="pmid">27756615</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0024">
<label>24</label>
<mixed-citation id="epi412238-cit-0024" publication-type="journal">
<string-name>
<surname>Chou</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Tseng</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CT</given-names>
</string-name>, et al. <article-title>Impaired ROS scavenging system in human induced pluripotent stem cells generated from patients with MERRF syndrome</article-title>. <source xml:lang="en"/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>23661</fpage>.<pub-id pub-id-type="pmid">27025901</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0025">
<label>25</label>
<mixed-citation id="epi412238-cit-0025" publication-type="journal">
<string-name>
<surname>Chi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells</article-title>. <source xml:lang="en"/>Stem Cell Reports
<year>2016</year>;<volume>5</volume>:<fpage>941</fpage>–<lpage>954</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0026">
<label>26</label>
<mixed-citation id="epi412238-cit-0026" publication-type="journal">
<string-name>
<surname>Yalcin</surname>
<given-names>O</given-names>
</string-name>. <article-title>Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies</article-title>. <source xml:lang="en"/>Seizure
<year>2012</year>;<volume>2</volume>:<fpage>79</fpage>–<lpage>86</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0027">
<label>27</label>
<mixed-citation id="epi412238-cit-0027" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Latchoumane</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2014</year>;<volume>32</volume>:<fpage>11828</fpage>–<lpage>11833</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0028">
<label>28</label>
<mixed-citation id="epi412238-cit-0028" publication-type="journal">
<string-name>
<surname>Anastasopoulou</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kurth</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Luders</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Generalized epilepsy syndromes and callosal thickness: differential effects between patients with juvenile myoclonic epilepsy and those with generalized tonic–clonic seizures alone</article-title>. <source xml:lang="en"/>Epilepsy Res
<year>2017</year>;<volume>129</volume>:<fpage>74</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">27923174</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0029">
<label>29</label>
<mixed-citation id="epi412238-cit-0029" publication-type="journal">
<string-name>
<surname>Gu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Sander</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Becker</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Genotypic association of exonic LGI4 polymorphisms and childhood absence epilepsy</article-title>. <source xml:lang="en"/>Neurogenetics
<year>2004</year>;<volume>1</volume>:<fpage>41</fpage>–<lpage>44</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0030">
<label>30</label>
<mixed-citation id="epi412238-cit-0030" publication-type="journal">
<string-name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sanchez‐Carpintero</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Deonna</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Early‐onset absence epilepsy and paroxysmal dyskinesia</article-title>. <source xml:lang="en"/>Epilepsia
<year>2002</year>;<volume>10</volume>:<fpage>1224</fpage>–<lpage>1229</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0031">
<label>31</label>
<mixed-citation id="epi412238-cit-0031" publication-type="journal">
<string-name>
<surname>Kadiyala</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Ferland</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Dissociation of spontaneous seizures and brainstem seizure thresholds in mice exposed to eight flurothyl‐induced generalized seizures</article-title>. <source xml:lang="en"/>Epilepsia Open
<year>2017</year>;<volume>1</volume>:<fpage>48</fpage>–<lpage>58</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0032">
<label>32</label>
<mixed-citation id="epi412238-cit-0032" publication-type="journal">
<string-name>
<surname>Kim</surname>
<given-names>JH</given-names>
</string-name>. <article-title>Grey and white matter alterations in juvenile myoclonic epilepsy: a comprehensive review</article-title>. <source xml:lang="en"/>J Epilepsy Res
<year>2017</year>;<volume>2</volume>:<fpage>77</fpage>–<lpage>88</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0033">
<label>33</label>
<mixed-citation id="epi412238-cit-0033" publication-type="journal">
<string-name>
<surname>Haki</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gumustas</surname>
<given-names>OG</given-names>
</string-name>, <string-name>
<surname>Bora</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Proton magnetic resonance spectroscopy study of bilateral thalamus in juvenile myoclonic epilepsy</article-title>. <source xml:lang="en"/>Seizure
<year>2007</year>;<volume>4</volume>:<fpage>287</fpage>–<lpage>295</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0034">
<label>34</label>
<mixed-citation id="epi412238-cit-0034" publication-type="journal">
<string-name>
<surname>Ji</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Generalized tonic‐clonic seizures: aberrant interhemispheric functional and anatomical connectivity</article-title>. <source xml:lang="en"/>Radiology
<year>2014</year>;<volume>3</volume>:<fpage>839</fpage>–<lpage>847</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0035">
<label>35</label>
<mixed-citation id="epi412238-cit-0035" publication-type="journal">
<string-name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</string-name>. <article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>. <source xml:lang="en"/>Cell
<year>2006</year>;<volume>4</volume>:<fpage>663</fpage>–<lpage>676</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0036">
<label>36</label>
<mixed-citation id="epi412238-cit-0036" publication-type="journal">
<string-name>
<surname>Higurashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Uchida</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lossin</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>A human Dravet syndrome model from patient induced pluripotent stem cells</article-title>. <source xml:lang="en"/>Mol Brain
<year>2013</year>;<volume>6</volume>:<fpage>19</fpage>.<pub-id pub-id-type="pmid">23639079</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0037">
<label>37</label>
<mixed-citation id="epi412238-cit-0037" publication-type="journal">
<string-name>
<surname>Livide</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Patriarchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Amenduni</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>GluD1 is a common altered player in neuronal differentiation from both MECP2‐mutated and CDKL5‐mutated iPS cells</article-title>. <source xml:lang="en"/>Eur J Hum Genet
<year>2015</year>;<volume>2</volume>:<fpage>195</fpage>–<lpage>201</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0038">
<label>38</label>
<mixed-citation id="epi412238-cit-0038" publication-type="journal">
<string-name>
<surname>Ryu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yokoyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamashita</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Induction of excitatory and inhibitory presynaptic differentiation by GluD1</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun
<year>2012</year>;<volume>1</volume>:<fpage>157</fpage>–<lpage>161</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0039">
<label>39</label>
<mixed-citation id="epi412238-cit-0039" publication-type="journal">
<string-name>
<surname>Kuroyanagi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yokoyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hirano</surname>
<given-names>T</given-names>
</string-name>. <article-title>Postsynaptic glutamate receptor delta family contributes to presynaptic terminal differentiation and establishment of synaptic transmission</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2009</year>;<volume>12</volume>:<fpage>4912</fpage>–<lpage>4916</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0040">
<label>40</label>
<mixed-citation id="epi412238-cit-0040" publication-type="journal">
<string-name>
<surname>Yoo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Carromeu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kwon</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>The L1 adhesion molecule normalizes neuritogenesis in Rett syndrome‐derived neural precursor cells</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun
<year>2017</year>;<volume>3–4</volume>:<fpage>504</fpage>–<lpage>510</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0041">
<label>41</label>
<mixed-citation id="epi412238-cit-0041" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Di Lucente</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>YC</given-names>
</string-name>, et al. <article-title>Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2‐null mice, a model of Rett syndrome</article-title>. <source xml:lang="en"/>Neurobiol Dis
<year>2018</year>;<volume>109</volume>(<issue>Pt A</issue>):<fpage>25</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">28927958</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0042">
<label>42</label>
<mixed-citation id="epi412238-cit-0042" publication-type="journal">
<string-name>
<surname>Chin</surname>
<given-names>EW</given-names>
</string-name>, <string-name>
<surname>Marcy</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Yoon</surname>
<given-names>SI</given-names>
</string-name>, et al. <article-title>Choline ameliorates disease phenotypes in human iPSC models of Rett syndrome</article-title>. <source xml:lang="en"/>Neuromolecular Med
<year>2016</year>;<volume>3</volume>:<fpage>364</fpage>–<lpage>377</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0043">
<label>43</label>
<mixed-citation id="epi412238-cit-0043" publication-type="journal">
<string-name>
<surname>de Souza</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Carromeu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Torres</surname>
<given-names>LB</given-names>
</string-name>, et al. <article-title>IGF1 neuronal response in the absence of MECP2 is dependent on TRalpha 3</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2017</year>;<volume>2</volume>:<fpage>270</fpage>–<lpage>281</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0044">
<label>44</label>
<mixed-citation id="epi412238-cit-0044" publication-type="journal">
<string-name>
<surname>Hartshorne</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</string-name>. <article-title>Purification of the saxitoxin receptor of the sodium channel from rat brain</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>1981</year>;<volume>7</volume>:<fpage>4620</fpage>–<lpage>4624</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0045">
<label>45</label>
<mixed-citation id="epi412238-cit-0045" publication-type="journal">
<string-name>
<surname>Kruger</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>O'Malley</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Hull</surname>
<given-names>JM</given-names>
</string-name>, et al. <article-title>beta1‐C121W is down but not out: epilepsy‐associated Scn1b‐C121W results in a deleterious gain‐of‐function</article-title>. <source xml:lang="en"/>J Neurosci
<year>2016</year>;<volume>23</volume>:<fpage>6213</fpage>–<lpage>6224</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0046">
<label>46</label>
<mixed-citation id="epi412238-cit-0046" publication-type="journal">
<string-name>
<surname>Namadurai</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yereddi</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Cusdin</surname>
<given-names>FS</given-names>
</string-name>, et al. <article-title>A new look at sodium channel beta subunits</article-title>. <source xml:lang="en"/>Open Biol
<year>2015</year>;<volume>1</volume>:<fpage>140192</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0047">
<label>47</label>
<mixed-citation id="epi412238-cit-0047" publication-type="journal">
<string-name>
<surname>Meng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>HQ</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>The SCN1A mutation database: updating information and analysis of the relationships among genotype, functional alteration, and phenotype</article-title>. <source xml:lang="en"/>Hum Mutat
<year>2015</year>;<volume>6</volume>:<fpage>573</fpage>–<lpage>580</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0048">
<label>48</label>
<mixed-citation id="epi412238-cit-0048" publication-type="journal">
<string-name>
<surname>Schuster</surname>
<given-names>H</given-names>
</string-name>. <article-title>Autosomal dominant hypertension with brachydactyly: an enigmatic form of monogenic hypertension</article-title>. <source xml:lang="en"/>Nephrol Dial Transplant
<year>1998</year>;<volume>6</volume>:<fpage>1337</fpage>–<lpage>1340</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0049">
<label>49</label>
<mixed-citation id="epi412238-cit-0049" publication-type="journal">
<string-name>
<surname>Pineda‐Trujillo</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Carrizosa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cornejo</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>A novel SCN1A mutation associated with severe GEFS+ in a large South American pedigree</article-title>. <source xml:lang="en"/>Seizure
<year>2005</year>;<volume>2</volume>:<fpage>123</fpage>–<lpage>128</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0050">
<label>50</label>
<mixed-citation id="epi412238-cit-0050" publication-type="journal">
<string-name>
<surname>Meisler</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Sharkey</surname>
<given-names>LM</given-names>
</string-name>. <article-title>Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects</article-title>. <source xml:lang="en"/>J Physiol
<year>2010</year>;<volume>588</volume>(<issue>Pt 11</issue>):<fpage>1841</fpage>–<lpage>1848</lpage>.<pub-id pub-id-type="pmid">20351042</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0051">
<label>51</label>
<mixed-citation id="epi412238-cit-0051" publication-type="journal">
<string-name>
<surname>Sun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Analysis of SCN1A mutation and parental origin in patients with Dravet syndrome</article-title>. <source xml:lang="en"/>J Hum Genet
<year>2010</year>;<volume>7</volume>:<fpage>421</fpage>–<lpage>427</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0052">
<label>52</label>
<mixed-citation id="epi412238-cit-0052" publication-type="journal">
<string-name>
<surname>Jiao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2013</year>;<volume>21</volume>:<fpage>4241</fpage>–<lpage>4252</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0053">
<label>53</label>
<mixed-citation id="epi412238-cit-0053" publication-type="journal">
<string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Pasca</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Portmann</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients</article-title>. <source xml:lang="en"/>Elife
<year>2016</year>;<volume>5</volume>:<fpage>pii: e13073</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0054">
<label>54</label>
<mixed-citation id="epi412238-cit-0054" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lopez‐Santiago</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Dravet syndrome patient‐derived neurons suggest a novel epilepsy mechanism</article-title>. <source xml:lang="en"/>Ann Neurol
<year>2013</year>;<volume>1</volume>:<fpage>128</fpage>–<lpage>139</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0055">
<label>55</label>
<mixed-citation id="epi412238-cit-0055" publication-type="journal">
<string-name>
<surname>Fusco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Russo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Galla</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>New Niemann‐Pick type C1 gene mutation associated with very severe disease course and marked early cerebellar vermis atrophy</article-title>. <source xml:lang="en"/>J Child Neurol
<year>2013</year>;<volume>12</volume>:<fpage>1694</fpage>–<lpage>1697</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0056">
<label>56</label>
<mixed-citation id="epi412238-cit-0056" publication-type="journal">
<string-name>
<surname>Rabenstein</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Peter</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Joost</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Decreased calcium flux in Niemann‐Pick type C1 patient‐specific iPSC‐derived neurons due to higher amount of calcium‐impermeable AMPA receptors</article-title>. <source xml:lang="en"/>Mol Cell Neurosci
<year>2017</year>;<volume>83</volume>:<fpage>27</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">28666962</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0057">
<label>57</label>
<mixed-citation id="epi412238-cit-0057" publication-type="journal">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Koscielska</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Signaling defects in iPSC‐derived fragile X premutation neurons</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2012</year>;<volume>17</volume>:<fpage>3795</fpage>–<lpage>3805</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0058">
<label>58</label>
<mixed-citation id="epi412238-cit-0058" publication-type="journal">
<string-name>
<surname>Pasca</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Portmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Using iPSC‐derived neurons to uncover cellular phenotypes associated with Timothy syndrome</article-title>. <source xml:lang="en"/>Nat Med
<year>2011</year>;<volume>12</volume>:<fpage>1657</fpage>–<lpage>1662</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0059">
<label>59</label>
<mixed-citation id="epi412238-cit-0059" publication-type="journal">
<string-name>
<surname>Krey</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Pasca</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Timothy syndrome is associated with activity‐dependent dendritic retraction in rodent and human neurons</article-title>. <source xml:lang="en"/>Nat Neurosci
<year>2013</year>;<volume>2</volume>:<fpage>201</fpage>–<lpage>209</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0060">
<label>60</label>
<mixed-citation id="epi412238-cit-0060" publication-type="journal">
<string-name>
<surname>Ali</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Bubolz</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Epilepsy is associated with ventricular alterations following convulsive status epilepticus in children</article-title>. <source xml:lang="en"/>Epilepsia Open
<year>2017</year>;<volume>4</volume>:<fpage>432</fpage>–<lpage>440</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0061">
<label>61</label>
<mixed-citation id="epi412238-cit-0061" publication-type="journal">
<string-name>
<surname>Noer</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Sudoyo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Lertrit</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged‐red fiber (MERRF) syndrome</article-title>. <source xml:lang="en"/>Am J Hum Genet
<year>1991</year>;<volume>4</volume>:<fpage>715</fpage>–<lpage>722</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0062">
<label>62</label>
<mixed-citation id="epi412238-cit-0062" publication-type="journal">
<string-name>
<surname>Hamalainen</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Manninen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Koivumaki</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Tissue‐ and cell‐type‐specific manifestations of heteroplasmic mtDNA 3243A&gt;G mutation in human induced pluripotent stem cell‐derived disease model</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2013</year>;<volume>38</volume>:<fpage>E3622</fpage>–<lpage>E3630</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0063">
<label>63</label>
<mixed-citation id="epi412238-cit-0063" publication-type="journal">
<string-name>
<surname>Barnes</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Polleux</surname>
<given-names>F</given-names>
</string-name>. <article-title>Establishment of axon‐dendrite polarity in developing neurons</article-title>. <source xml:lang="en"/>Annu Rev Neurosci
<year>2009</year>;<volume>32</volume>:<fpage>347</fpage>–<lpage>381</lpage>.<pub-id pub-id-type="pmid">19400726</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0064">
<label>64</label>
<mixed-citation id="epi412238-cit-0064" publication-type="journal">
<string-name>
<surname>Ohtaka‐Maruyama</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Endo</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Synaptic transmission from subplate neurons controls radial migration of neocortical neurons</article-title>. <source xml:lang="en"/>Science
<year>2018</year>;<volume>6386</volume>:<fpage>313</fpage>–<lpage>317</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0065">
<label>65</label>
<mixed-citation id="epi412238-cit-0065" publication-type="book">
<string-name>
<surname>Khaikin</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mercimek‐Mahmutoglu</surname>
<given-names>S</given-names>
</string-name>. <chapter-title>STXBP1 encephalopathy with epilepsy</chapter-title> In <person-group person-group-type="editor"><name><surname>Adam</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ardinger</surname><given-names>HH</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>RA</given-names></name></person-group>, et al. (Eds) <source xml:lang="en"/>GeneReviews(R). <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington</publisher-name>; <year>1993</year>:<fpage>1993</fpage>–<lpage>2018</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0066">
<label>66</label>
<mixed-citation id="epi412238-cit-0066" publication-type="journal">
<string-name>
<surname>Patzke</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</string-name>. <article-title>The conditional KO approach: Cre/Lox technology in human neurons</article-title>. <source xml:lang="en"/>Rare Dis
<year>2016</year>;<volume>1</volume>:<fpage>e1131884</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0067">
<label>67</label>
<mixed-citation id="epi412238-cit-0067" publication-type="journal">
<string-name>
<surname>Yamashita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Chiyonobu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Mislocalization of syntaxin‐1 and impaired neurite growth observed in a human iPSC model for STXBP1‐related epileptic encephalopathy</article-title>. <source xml:lang="en"/>Epilepsia
<year>2016</year>;<volume>4</volume>:<fpage>e81</fpage>–<lpage>e86</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0068">
<label>68</label>
<mixed-citation id="epi412238-cit-0068" publication-type="journal">
<string-name>
<surname>Phelan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>McDermid</surname>
<given-names>HE</given-names>
</string-name>. <article-title>The 22q13.3 deletion syndrome (Phelan‐McDermid syndrome)</article-title>. <source xml:lang="en"/>Mol Syndromol
<year>2012</year>; <volume>2</volume>:<fpage>186</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">22670140</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0069">
<label>69</label>
<mixed-citation id="epi412238-cit-0069" publication-type="journal">
<string-name>
<surname>Shcheglovitov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shcheglovitova</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Yazawa</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients</article-title>. <source xml:lang="en"/>Nature
<year>2013</year>;<volume>7475</volume>:<fpage>267</fpage>–<lpage>271</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0070">
<label>70</label>
<mixed-citation id="epi412238-cit-0070" publication-type="journal">
<string-name>
<surname>Holder</surname>
<given-names>JL</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Quach</surname>
<given-names>MM</given-names>
</string-name>. <article-title>The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss‐of‐function mutations</article-title>. <source xml:lang="en"/>Epilepsia
<year>2016</year>;<volume>10</volume>:<fpage>1651</fpage>–<lpage>1659</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0071">
<label>71</label>
<mixed-citation id="epi412238-cit-0071" publication-type="journal">
<string-name>
<surname>Benarroch</surname>
<given-names>EE</given-names>
</string-name>. <article-title>HCN channels: function and clinical implications</article-title>. <source xml:lang="en"/>Neurology
<year>2013</year>;<volume>3</volume>:<fpage>304</fpage>–<lpage>310</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0072">
<label>72</label>
<mixed-citation id="epi412238-cit-0072" publication-type="journal">
<string-name>
<surname>Biel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wahl‐Schott</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Michalakis</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Hyperpolarization‐activated cation channels: from genes to function</article-title>. <source xml:lang="en"/>Physiol Rev
<year>2009</year>;<volume>3</volume>:<fpage>847</fpage>–<lpage>885</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0073">
<label>73</label>
<mixed-citation id="epi412238-cit-0073" publication-type="journal">
<string-name>
<surname>Kase</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Imoto</surname>
<given-names>K</given-names>
</string-name>. <article-title>The role of HCN channels on membrane excitability in the nervous system</article-title>. <source xml:lang="en"/>J Signal Transduct
<year>2012</year>;<volume>2012</volume>:<fpage>619747</fpage>.<pub-id pub-id-type="pmid">22934165</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0074">
<label>74</label>
<mixed-citation id="epi412238-cit-0074" publication-type="journal">
<string-name>
<surname>Fauth</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Steindl</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Toutain</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>A recurrent germline mutation in the PIGA gene causes Simpson‐Golabi‐Behmel syndrome type 2</article-title>. <source xml:lang="en"/>Am J Med Genet A
<year>2016</year>;<volume>2</volume>:<fpage>392</fpage>–<lpage>402</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0075">
<label>75</label>
<mixed-citation id="epi412238-cit-0075" publication-type="journal">
<string-name>
<surname>Yuan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Baines</surname>
<given-names>AC</given-names>
</string-name>, et al. <article-title>A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement‐mediated toxicity in a human iPSC model</article-title>. <source xml:lang="en"/>PLoS ONE
<year>2017</year>;<volume>4</volume>:<fpage>e0174074</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0076">
<label>76</label>
<mixed-citation id="epi412238-cit-0076" publication-type="journal">
<string-name>
<surname>Gerhardt</surname>
<given-names>J</given-names>
</string-name>. <article-title>Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling</article-title>. <source xml:lang="en"/>Brain Res
<year>2017</year>;<volume>1656</volume>:<fpage>55</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">26475977</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0077">
<label>77</label>
<mixed-citation id="epi412238-cit-0077" publication-type="journal">
<string-name>
<surname>Urbach</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bar‐Nur</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Daley</surname>
<given-names>GQ</given-names>
</string-name>, et al. <article-title>Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells</article-title>. <source xml:lang="en"/>Cell Stem Cell
<year>2010</year>;<volume>5</volume>:<fpage>407</fpage>–<lpage>411</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0078">
<label>78</label>
<mixed-citation id="epi412238-cit-0078" publication-type="journal">
<string-name>
<surname>Sheridan</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Theriault</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Reis</surname>
<given-names>SA</given-names>
</string-name>, et al. <article-title>Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome</article-title>. <source xml:lang="en"/>PLoS ONE
<year>2011</year>;<volume>10</volume>:<fpage>e26203</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0079">
<label>79</label>
<mixed-citation id="epi412238-cit-0079" publication-type="journal">
<string-name>
<surname>Telias</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Segal</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ben‐Yosef</surname>
<given-names>D</given-names>
</string-name>. <article-title>Neural differentiation of fragile X human embryonic stem cells reveals abnormal patterns of development despite successful neurogenesis</article-title>. <source xml:lang="en"/>Dev Biol
<year>2013</year>;<volume>1</volume>:<fpage>32</fpage>–<lpage>45</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0080">
<label>80</label>
<mixed-citation id="epi412238-cit-0080" publication-type="journal">
<string-name>
<surname>Doers</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Musser</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Nichol</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>iPSC‐derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth</article-title>. <source xml:lang="en"/>Stem Cells Dev
<year>2014</year>;<volume>15</volume>:<fpage>1777</fpage>–<lpage>1787</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0081">
<label>81</label>
<mixed-citation id="epi412238-cit-0081" publication-type="journal">
<string-name>
<surname>de Esch</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Ghazvini</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Loos</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation</article-title>. <source xml:lang="en"/>Stem Cell Reports
<year>2014</year>;<volume>4</volume>:<fpage>548</fpage>–<lpage>555</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0082">
<label>82</label>
<mixed-citation id="epi412238-cit-0082" publication-type="journal">
<string-name>
<surname>Lu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation</article-title>. <source xml:lang="en"/>Sci China Life Sci
<year>2016</year>;<volume>11</volume>:<fpage>1093</fpage>–<lpage>1105</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0083">
<label>83</label>
<mixed-citation id="epi412238-cit-0083" publication-type="journal">
<string-name>
<surname>Halevy</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Czech</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Benvenisty</surname>
<given-names>N</given-names>
</string-name>. <article-title>Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells</article-title>. <source xml:lang="en"/>Stem Cell Reports
<year>2015</year>;<volume>1</volume>:<fpage>37</fpage>–<lpage>46</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0084">
<label>84</label>
<mixed-citation id="epi412238-cit-0084" publication-type="journal">
<string-name>
<surname>Achuta</surname>
<given-names>VS</given-names>
</string-name>, <string-name>
<surname>Moykkynen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Peteri</surname>
<given-names>UK</given-names>
</string-name>, et al. <article-title>Functional changes of AMPA responses in human induced pluripotent stem cell‐derived neural progenitors in fragile X syndrome</article-title>. <source xml:lang="en"/>Sci Signal
<year>2018</year>;<volume>11</volume>:<fpage>pii: eaan8784</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0085">
<label>85</label>
<mixed-citation id="epi412238-cit-0085" publication-type="journal">
<string-name>
<surname>Lee</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Ramirez</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Franco</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10</article-title>. <source xml:lang="en"/>Cell Mol Life Sci
<year>2014</year>;<volume>14</volume>:<fpage>2747</fpage>–<lpage>2758</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0086">
<label>86</label>
<mixed-citation id="epi412238-cit-0086" publication-type="journal">
<string-name>
<surname>Chamberlain</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>KY</given-names>
</string-name>, et al. <article-title>Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader‐Willi syndromes</article-title>. <source xml:lang="en"/>Proc Natl Acad Sci USA
<year>2010</year>;<volume>41</volume>:<fpage>17668</fpage>–<lpage>17673</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0087">
<label>87</label>
<mixed-citation id="epi412238-cit-0087" publication-type="journal">
<string-name>
<surname>Okuno</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Nakabayashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Changeability of the fully methylated status of the 15q11.2 region in induced pluripotent stem cells derived from a patient with Prader‐Willi syndrome</article-title>. <source xml:lang="en"/>Congenit Anom (Kyoto)
<year>2017</year>;<volume>4</volume>:<fpage>96</fpage>–<lpage>103</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0088">
<label>88</label>
<mixed-citation id="epi412238-cit-0088" publication-type="journal">
<string-name>
<surname>Stanurova</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Neureiter</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hiber</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Angelman syndrome‐derived neurons display late onset of paternal UBE3A silencing</article-title>. <source xml:lang="en"/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>30792</fpage>.<pub-id pub-id-type="pmid">27484051</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0089">
<label>89</label>
<mixed-citation id="epi412238-cit-0089" publication-type="journal">
<string-name>
<surname>Fink</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Germain</surname>
<given-names>ND</given-names>
</string-name>, et al. <article-title>Disrupted neuronal maturation in Angelman syndrome‐derived induced pluripotent stem cells</article-title>. <source xml:lang="en"/>Nat Commun
<year>2017</year>;<volume>8</volume>:<fpage>15038</fpage>.<pub-id pub-id-type="pmid">28436452</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0090">
<label>90</label>
<mixed-citation id="epi412238-cit-0090" publication-type="journal">
<string-name>
<surname>Chen</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Hsiao</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Sirois</surname>
<given-names>CL</given-names>
</string-name>, et al. <article-title>RBFOX1 and RBFOX2 are dispensable in iPSCs and iPSC‐derived neurons and do not contribute to neural‐specific paternal UBE3A silencing</article-title>. <source xml:lang="en"/>Sci Rep
<year>2016</year>;<volume>6</volume>:<fpage>25368</fpage>.<pub-id pub-id-type="pmid">27146458</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0091">
<label>91</label>
<mixed-citation id="epi412238-cit-0091" publication-type="journal">
<string-name>
<surname>Shimojima</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sugiura</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Genomic copy number variations at 17p13.3 and epileptogenesis</article-title>. <source xml:lang="en"/>Epilepsy Res
<year>2010</year>;<volume>2–3</volume>:<fpage>303</fpage>–<lpage>309</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0092">
<label>92</label>
<mixed-citation id="epi412238-cit-0092" publication-type="journal">
<string-name>
<surname>Reiner</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Carrozzo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Isolation of a Miller‐Dieker lissencephaly gene containing G protein beta‐subunit‐like repeats</article-title>. <source xml:lang="en"/>Nature
<year>1993</year>;<volume>6439</volume>:<fpage>717</fpage>–<lpage>721</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0093">
<label>93</label>
<mixed-citation id="epi412238-cit-0093" publication-type="journal">
<string-name>
<surname>Qian</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>
<given-names>HN</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>MM</given-names>
</string-name>, et al. <article-title>Brain‐region‐specific organoids using mini‐bioreactors for modeling ZIKV exposure</article-title>. <source xml:lang="en"/>Cell
<year>2016</year>;<volume>5</volume>:<fpage>1238</fpage>–<lpage>1254</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0094">
<label>94</label>
<mixed-citation id="epi412238-cit-0094" publication-type="journal">
<string-name>
<surname>Stahl</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Walcher</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>De Juan Romero</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Trnp1 regulates expansion and folding of the mammalian cerebral cortex by control of radial glial fate</article-title>. <source xml:lang="en"/>Cell
<year>2013</year>;<volume>3</volume>:<fpage>535</fpage>–<lpage>549</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0095">
<label>95</label>
<mixed-citation id="epi412238-cit-0095" publication-type="journal">
<string-name>
<surname>Reillo</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>de Juan Romero</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Garcia‐Cabezas</surname>
<given-names>MA</given-names>
</string-name>, et al. <article-title>A role for intermediate radial glia in the tangential expansion of the mammalian cerebral cortex</article-title>. <source xml:lang="en"/>Cereb Cortex
<year>2011</year>;<volume>7</volume>:<fpage>1674</fpage>–<lpage>1694</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0096">
<label>96</label>
<mixed-citation id="epi412238-cit-0096" publication-type="journal">
<string-name>
<surname>Iefremova</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Manikakis</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Krefft</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>An organoid‐based model of cortical development identifies non‐cell‐autonomous defects in Wnt signaling contributing to Miller‐Dieker syndrome</article-title>. <source xml:lang="en"/>Cell Rep
<year>2017</year>;<volume>1</volume>:<fpage>50</fpage>–<lpage>59</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0097">
<label>97</label>
<mixed-citation id="epi412238-cit-0097" publication-type="journal">
<string-name>
<surname>Katsarou</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Moshe</surname>
<given-names>SL</given-names>
</string-name>, <string-name>
<surname>Galanopoulou</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Interneuronopathies and their role in early life epilepsies and neurodevelopmental disorders</article-title>. <source xml:lang="en"/>Epilepsia Open
<year>2017</year>;<volume>3</volume>:<fpage>284</fpage>–<lpage>306</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0098">
<label>98</label>
<mixed-citation id="epi412238-cit-0098" publication-type="journal">
<string-name>
<surname>Brenner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Boespflug‐Tanguy</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease</article-title>. <source xml:lang="en"/>Nat Genet
<year>2001</year>;<volume>1</volume>:<fpage>117</fpage>–<lpage>120</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0099">
<label>99</label>
<mixed-citation id="epi412238-cit-0099" publication-type="journal">
<string-name>
<surname>Kondo</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Funayama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Miyake</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Erratum to: modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes</article-title>. <source xml:lang="en"/>Acta Neuropathol Commun
<year>2016</year>;<volume>1</volume>:<fpage>101</fpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0100">
<label>100</label>
<mixed-citation id="epi412238-cit-0100" publication-type="journal">
<string-name>
<surname>Santello</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bezzi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Volterra</surname>
<given-names>A</given-names>
</string-name>. <article-title>TNFalpha controls glutamatergic gliotransmission in the hippocampal dentate gyrus</article-title>. <source xml:lang="en"/>Neuron
<year>2011</year>;<volume>5</volume>:<fpage>988</fpage>–<lpage>1001</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0101">
<label>101</label>
<mixed-citation id="epi412238-cit-0101" publication-type="journal">
<string-name>
<surname>Ishii</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shoji</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Human induced pluripotent stem cell (hiPSC)‐derived neurons respond to convulsant drugs when co‐cultured with hiPSC‐derived astrocytes</article-title>. <source xml:lang="en"/>Toxicology
<year>2017</year>;<volume>389</volume>:<fpage>130</fpage>–<lpage>138</lpage>.<pub-id pub-id-type="pmid">28666936</pub-id></mixed-citation>
</ref>
<ref id="epi412238-bib-0102">
<label>102</label>
<mixed-citation id="epi412238-cit-0102" publication-type="journal">
<string-name>
<surname>Odawara</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Saitoh</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Alhebshi</surname>
<given-names>AH</given-names>
</string-name>, et al. <article-title>Long‐term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell‐derived neuron and astrocyte co‐culture</article-title>. <source xml:lang="en"/>Biochem Biophys Res Commun
<year>2014</year>;<volume>4</volume>:<fpage>1176</fpage>–<lpage>1181</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0103">
<label>103</label>
<mixed-citation id="epi412238-cit-0103" publication-type="journal">
<string-name>
<surname>Tang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>Astroglial cells regulate the developmental timeline of human neurons differentiated from induced pluripotent stem cells</article-title>. <source xml:lang="en"/>Stem Cell Res
<year>2013</year>;<volume>2</volume>:<fpage>743</fpage>–<lpage>757</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0104">
<label>104</label>
<mixed-citation id="epi412238-cit-0104" publication-type="journal">
<string-name>
<surname>Williams</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>Zhong</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Mohamed</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Mutant astrocytes differentiated from Rett syndrome patients‐specific iPSCs have adverse effects on wild‐type neurons</article-title>. <source xml:lang="en"/>Hum Mol Genet
<year>2014</year>;<volume>11</volume>:<fpage>2968</fpage>–<lpage>2980</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0105">
<label>105</label>
<mixed-citation id="epi412238-cit-0105" publication-type="journal">
<string-name>
<surname>Lischka</surname>
<given-names>FW</given-names>
</string-name>, <string-name>
<surname>Efthymiou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Neonatal mouse cortical but not isogenic human astrocyte feeder layers enhance the functional maturation of induced pluripotent stem cell‐derived neurons in culture</article-title>. <source xml:lang="en"/>Glia
<year>2018</year>;<volume>4</volume>:<fpage>725</fpage>–<lpage>748</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0106">
<label>106</label>
<mixed-citation id="epi412238-cit-0106" publication-type="journal">
<string-name>
<surname>Maezawa</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Swanberg</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Harvey</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions</article-title>. <source xml:lang="en"/>J Neurosci
<year>2009</year>;<volume>16</volume>:<fpage>5051</fpage>–<lpage>5061</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0107">
<label>107</label>
<mixed-citation id="epi412238-cit-0107" publication-type="journal">
<string-name>
<surname>Shimojima</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Sugawara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shichiji</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Loss‐of‐function mutation of collybistin is responsible for X‐linked mental retardation associated with epilepsy</article-title>. <source xml:lang="en"/>J Hum Genet
<year>2011</year>;<volume>8</volume>:<fpage>561</fpage>–<lpage>565</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0108">
<label>108</label>
<mixed-citation id="epi412238-cit-0108" publication-type="journal">
<string-name>
<surname>Harvey</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Duguid</surname>
<given-names>IC</given-names>
</string-name>, <string-name>
<surname>Alldred</surname>
<given-names>MJ</given-names>
</string-name>, et al. <article-title>The GDP‐GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering</article-title>. <source xml:lang="en"/>J Neurosci
<year>2004</year>;<volume>25</volume>:<fpage>5816</fpage>–<lpage>5826</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0109">
<label>109</label>
<mixed-citation id="epi412238-cit-0109" publication-type="journal">
<string-name>
<surname>Ebrahimi‐Fakhari</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sahin</surname>
<given-names>M</given-names>
</string-name>. <article-title>Autism and the synapse: emerging mechanisms and mechanism‐based therapies</article-title>. <source xml:lang="en"/>Curr Opin Neurol
<year>2015</year>;<volume>2</volume>:<fpage>91</fpage>–<lpage>102</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0110">
<label>110</label>
<mixed-citation id="epi412238-cit-0110" publication-type="journal">
<string-name>
<surname>Ebrahimi‐Fakhari</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Saffari</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wahlster</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Cell Rep
<year>2016</year>;<volume>4</volume>:<fpage>1053</fpage>–<lpage>1070</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0111">
<label>111</label>
<mixed-citation id="epi412238-cit-0111" publication-type="journal">
<string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Abnormal neural progenitor cells differentiated from induced pluripotent stem cells partially mimicked development of TSC2 neurological abnormalities</article-title>. <source xml:lang="en"/>Stem Cell Reports
<year>2017</year>;<volume>4</volume>:<fpage>883</fpage>–<lpage>893</lpage>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0112">
<label>112</label>
<mixed-citation id="epi412238-cit-0112" publication-type="journal">
<string-name>
<surname>Sundberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tochitsky</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Buchholz</surname>
<given-names>DE</given-names>
</string-name>, et al. <article-title>Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin</article-title>. <source xml:lang="en"/>Mol Psychiatry
<year>2018</year>; <pub-id pub-id-type="doi">10.1038/s41380-018-0018-4</pub-id>.</mixed-citation>
</ref>
<ref id="epi412238-bib-0113">
<label>113</label>
<mixed-citation id="epi412238-cit-0113" publication-type="journal">
<string-name>
<surname>Parent</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Reprogramming patient‐derived cells to study the epilepsies</article-title>. <source xml:lang="en"/>Nat Neurosci
<year>2015</year>;<volume>3</volume>:<fpage>360</fpage>–<lpage>366</lpage>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>